Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Bergin

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2009
IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosisEmer P Reeves, Michael Williamson, Barry Byrne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2014
Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individualsKillian Hurley, Noreen Lacey, Ciara A O'Dwyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2014
Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lungIsabel Vega-Carrascal, David A Bergin, Oliver J McElvaney, et al.
The Journal of Biological Chemistry|September 6, 2008
Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathwayDavid A Bergin, Catherine M Greene, Erwin E Sterchi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Endothelial progenitor cells in mothers of low-birthweight infants: a link between defective placental vascularization and increased cardiovascular risk?Thomas F J King, David A Bergin, Etaoin M Kent, et al.
ERJ Open Research|December 9, 2021
<i>In vitro</i> and <i>in vivo</i> modulation of NADPH oxidase activity and reactive oxygen species production in human neutrophils by α<sub>1</sub>-antitrypsinPadraig Hawkins, Thomas McEnery, Claudie Gabillard-Lefort, et al.
The Journal of Clinical Investigation|November 10, 2010
α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8David A Bergin, Emer P Reeves, Paula Meleady, et al.
Journal of Proteome Research|December 17, 2013
Increased outer arm and core fucose residues on the N-glycans of mutated alpha-1 antitrypsin protein from alpha-1 antitrypsin deficient individualsCormac McCarthy, Radka Saldova, M Emmet O'Brien, et al.
Blood|June 18, 2014
A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapyKerstin Pohl, Elaine Hayes, Joanne Keenan, et al.
Molecular Immunology|December 3, 2014
The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosisOliver J McElvaney, Niamh O'Reilly, Michelle White, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2009
IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosisEmer P Reeves, Michael Williamson, Barry Byrne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2014
Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individualsKillian Hurley, Noreen Lacey, Ciara A O'Dwyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2014
Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lungIsabel Vega-Carrascal, David A Bergin, Oliver J McElvaney, et al.
The Journal of Biological Chemistry|September 6, 2008
Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathwayDavid A Bergin, Catherine M Greene, Erwin E Sterchi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Endothelial progenitor cells in mothers of low-birthweight infants: a link between defective placental vascularization and increased cardiovascular risk?Thomas F J King, David A Bergin, Etaoin M Kent, et al.
ERJ Open Research|December 9, 2021
<i>In vitro</i> and <i>in vivo</i> modulation of NADPH oxidase activity and reactive oxygen species production in human neutrophils by α<sub>1</sub>-antitrypsinPadraig Hawkins, Thomas McEnery, Claudie Gabillard-Lefort, et al.
The Journal of Clinical Investigation|November 10, 2010
α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8David A Bergin, Emer P Reeves, Paula Meleady, et al.
Journal of Proteome Research|December 17, 2013
Increased outer arm and core fucose residues on the N-glycans of mutated alpha-1 antitrypsin protein from alpha-1 antitrypsin deficient individualsCormac McCarthy, Radka Saldova, M Emmet O'Brien, et al.
Blood|June 18, 2014
A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapyKerstin Pohl, Elaine Hayes, Joanne Keenan, et al.
Molecular Immunology|December 3, 2014
The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosisOliver J McElvaney, Niamh O'Reilly, Michelle White, et al.
Pageof 3